Europe risks losing the race to win the favor of pharmaceutical companies, CEO at Roche Severin Schwan tells business daily Børsen.
He highlights easier access to health data and a willingness to reward innovation as deciding factors in explaining why the US and Asia are surpassing Europe in the pharmaceutical industry.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.